Aberdeen Group
COLL icon

Aberdeen Group’s Collegium Pharmaceutical COLL Stock Holding History

Aberdeen Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-48,716
Closed -$1M – 919
2019
Q4 		$1M Buy
+48,716
New +$812K ﹤0.01% 806
2018
Q2 		– Sell
-28,781
Closed -$735K – 901
2018
Q1 		$735K Buy
+28,781
New +$686K ﹤0.01% 753

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Aberdeen Group's COLL Position: Q1 2020 in Review

Aberdeen Group sold out of Collegium Pharmaceutical (COLL) in Q1 2020, closing a stake of 48,716 shares — an estimated $1M sold.

Aberdeen Group first reported a position in COLL in Q1 2018 and held it in 2 quarters. The position peaked at $1M in Q4 2019. 159 funds tracked by Wall St. Rank hold COLL as of Q1 2020.

  • Aberdeen Group reported no remaining Collegium Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Aberdeen Group sold 48,716 Collegium Pharmaceutical shares in Q1 2020, an estimated $1M.
  • Aberdeen Group first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 2 quarters.
  • Aberdeen Group's Collegium Pharmaceutical position peaked at $1M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2020.

Based on Aberdeen Group's 13F filing for Q1 2020, filed 13 May 2020.